Combination therapy comprising Anti-PLA2g2d antibodies and uses thereof
TW202626095APending Publication Date: 2026-07-01APEXIMMUNE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114135395
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-13
- Filing Date
- 2025-09-15
- Publication Date
- 2026-07-01
Abstract
The present application provides methods of treating diseases or conditions in an individual comprising administration of anti-PLA2G2D antibodies, and inhibitors that stimulate phagocytosis.
Need to check novelty before this filing date? Find Prior Art